Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

ANALYST DOWNPLAYS GM-CSF PATENT NEWS

Sep. 27, 1991

CENTOCOR RAISES SIZE OF DEBENTURES

Sep. 27, 1991

CHIRON/CETUS MERGER PASSES FTC DEADLINE

Sep. 27, 1991

MULTIDRUG STRATEGY TO COMBAT AIDS

Sep. 27, 1991

COMBINATION TEST APPROVED FOR HIV-1, 2

Sep. 27, 1991

SUITS OPPOSE GI MERGER WITH AHP

Sep. 27, 1991

FDA PANEL RECOMMENDATION SPURS CHIRON

Sep. 27, 1991

SBIR GRANTED FOR AMYLIN MABS

Sep. 27, 1991

OXFORD COMPLETES $8M FINANCING

Sep. 27, 1991

HEMACARE EXTENDS WARRANT EXPIRATION

Sep. 27, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.